Rifampin in dermatology.
Nikolai
N
Tsankov
Irena
I
Angelova
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D004347:Drug Interactions; D005260:Female; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D012293:Rifampin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D012293:Rifampin